Fibroid Ablation Study - Large Fibroids
The purpose of this study is to establish the effectiveness and confirm the safety of the VizAblate System in the ablation of large (\> 5 cm) symptomatic uterine fibroids.
Leiomyoma|Uterine Fibroids|Menorrhagia
DEVICE: VizAblate System
Mean percentage change in target fibroid perfused volume, Baseline, 3 months, 12 months
Number of adverse events, Procedure safety will be assessed by recording all adverse events that occur on the day of the procedure. Longer-term safety will be assessed by recording at each follow-up visit any untoward medical occurrence since baseline. Each adverse event will be assessed for severity and relationship to study device., Procedure through 12 mo|Percentage reduction in Symptom Severity Score (SSS) subscale of the Uterine Fibroid Symptom and Quality-of-Life (UFS-QOL) Questionnaire, Baseline through 12 months|Rate of surgical reintervention for menorrhagia, through 12 months|Return to normal daily activity, 2 weeks or until returned to normal activity|Percentage reduction in Menstrual Pictogram score, through 12 months
The purpose of this study is to establish the effectiveness and confirm the safety of the VizAblate System in the ablation of large (\> 5 cm) symptomatic uterine fibroids.